Effects of intensified metabolic control on CNS function in type 2 diabetes

Psychoneuroendocrinology

Volumn 36, Issue 1, 2011, Pages 77-86

  Cooray, Gerald ^a,b   Nilsson, Erik ^a   Wahlin, Åke ^c   Laukka, Erika J ^b   Brismar, Kerstin ^a,b   Brismar, Tom ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Connectivity; Diabetes type 2; EEG; Event related potential; Human; Hyperglycemia

Indexed keywords

ADULT; AGED; ALPHA RHYTHM; AMPLITUDE MODULATION; ARTICLE; BETA RHYTHM; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LATENT PERIOD; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM; SEMANTIC MEMORY; THETA RHYTHM; VERBAL MEMORY;

AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; SPEECH DISORDERS;

EID: 78649902560     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.06.009     Document Type: Article

References (50)

1. Backman L., Forsell Y. Episodic memory functioning in a community-based sample of old adults with major depression: utilization of cognitive support. J. Abnorm. Psychol. 1994, 103:361-370.
2. Bowler J.V., Hadar U., Wade J.P. Cognition in stroke. Acta Neurol. Scand. 1994, 90:424-429.
3. Brands A.M., Biessels G.J., de Haan E.H., Kappelle L.J., Kessels R.P. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005, 28:726-735.
4. Brismar T., Hyllienmark L., Ekberg K., Johansson B.L. Loss of temporal lobe beta power in young adults with type 1 diabetes mellitus. Neuroreport 2002, 13:2469-2473.
5. Brismar T., Maurex L., Cooray G., Juntti-Berggren L., Lindstrom P., Ekberg K., Adner N., Andersson S. Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology 2007, 32:1041-1051.
6. Convit A., Wolf O.T., Tarshish C., de Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2019-2022.
7. Cooray G.K., Maurex L., Brismar T. Cognitive impairment correlates to low auditory event-related potential amplitudes in type 1 diabetes. Psychoneuroendocrinology 2008, 33:942-950.
8. de Frias C.M., Bunce D., Wahlin A., Adolfsson R., Sleegers K., Cruts M., Van Broeckhoven C., Nilsson L.G. Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J. Gerontol. B: Psychol. Sci. Soc. Sci. 2007, 62:P112-118.
9. Frystyk J., Hojlund K., Rasmussen K.N., Jorgensen S.P., Wildner-Christensen M., Orskov H. Development and clinical evaluation of a novel immunoassay for the binary complex of IGF-I and IGF-binding protein-1 in human serum. J. Clin. Endocrinol. Metab. 2002, 87:260-266.
10. Gradman T.J., Laws A., Thompson L.W., Reaven G.M. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 1993, 41:1305-1312.
11. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Narayan K.M., Cummings S.R. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 2000, 160:174-180.
12. Grodstein F., Chen J., Wilson R.S., Manson J.E. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001, 24:1060-1065.
13. Hilding A., Brismar K., Degerblad M., Thoren M., Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J. Clin. Endocrinol. Metab. 1995, 80:2646-2652.
14. Hyllienmark L., Maltez J., Dandenell A., Ludvigsson J., Brismar T. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes. Diabetologia 2005, 48:412-419.
15. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., Burwood A., Weinger K., Bayless M., Dahms W., Harth J. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 2007, 356:1842-1852.
16. Jarrett R.J. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither?. Diabetologia 1984, 26:99-102.
17. Jongen C., van der Grond J., Kappelle L.J., Biessels G.J., Viergever M.A., Pluim J.P. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 2007, 50:1509-1516.
18. Knott V., Messier C., Mahoney C., Gagnon M. Glucose and glucoregulatory modulation of memory scanning, event-related potentials and EEG in elderly subjects. Neuropsychobiology 2001, 44:156-166.
19. Kodl C.T., Franc D.T., Rao J.P., Anderson F.S., Thomas W., Mueller B.A., Lim K.O., Seaquist E.R. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 2008, 57:3083-3089.
20. Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 2008, 29:494-511.
21. Kramer L., Fasching P., Madl C., Schneider B., Damjancic P., Waldhausl W., Irsigler K., Grimm G. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes 1998, 47:1909-1914.
22. Kurita A., Katayama K., Mochio S. Neurophysiological evidence for altered higher brain functions in NIDDM. Diabetes Care 1996, 19:360-364.
23. Lezak M.D. Neuropsychological Assessment 1995, Oxford University Press, New York.
24. Longstreth W.T., Arnold A.M., Manolio T.A., Burke G.L., Bryan N., Jungreis C.A., O'Leary D., Enright P.L., Fried L. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology 2000, 19:30-42.
25. Mahalanobis, P.C., Lahiri, D.B., 1965. Contributions to Statistics. Presented to Professor Mahalanobis, P.C. on the occasion of his 70th birthday. Rao, C.R., in collaboration with Lahiri, D.B., and others, etc. (Eds.), Pergamon Press, Oxford; Statistical Publishing Society: Calcutta; Calcutta printed, pp. 528.
26. Maltez J., Hyllienmark L., Nikulin V.V., Brismar T. Time course and variability of power in different frequency bands of EEG during resting conditions. Neurophysiol. Clin. 2004, 34:195-202.
27. Meneilly G.S., Cheung E., Tessier D., Yakura C., Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J. Gerontol. 1993, 48:M117-121.
28. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol. Aging 2005, 26(Suppl. 1):26-30.
29. Mooradian A.D., Perryman K., Fitten J., Kavonian G.D., Morley J.E. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch. Intern. Med. 1988, 148:2369-2372.
30. Munshi M., Grande L., Hayes M., Ayres D., Suhl E., Capelson R., Lin S., Milberg W., Weinger K. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006, 29:1794-1799.
31. Mussell M., Hewer W., Kulzer B., Bergis K., Rist F. Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with type 2 diabetes. Diabet Med. 2004, 21:1253-1256.
32. Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Adler R.G., Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998, 21:379-384.
33. Perlmuter L.C., Hakami M.K., Hodgson-Harrington C., Ginsberg J., Katz J., Singer D.E., Nathan D.M. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am. J. Med. 1984, 77:1043-1048.
34. Polich J., Pitzer A. P300 and Alzheimer's disease: oddball task difficulty and modality effects. Electroencephalogr. Clin. Neurophysiol. 1999, Suppl. 50:281-287.
35. Povoa G., Roovete A., Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol. (Copenh) 1984, 107:563-570.
36. Pozzessere G., Valle E., de Crignis S., Cordischi V.M., Fattapposta F., Rizzo P.A., Pietravalle P., Cristina G., Morano S., di Mario U. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric tests. Diabetes 1991, 40:952-958.
37. Reaven G.M., Thompson L.W., Nahum D., Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990, 13:16-21.
38. Ryan C.M., Williams T.M., Orchard T.J., Finegold D.N. Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 1992, 41:107-113.
39. Schmidt R., Launer L.J., Nilsson L.G., Pajak A., Sans S., Berger K., Breteler M.M., de Ridder M., Dufouil C., Fuhrer R., Giampaoli S., Hofman A. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004, 53:687-692.
40. Stam C.J., Nolte G., Daffertshofer A. Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources. Hum. Brain Mapp. 2007, 28:1178-1193.
41. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997, 20:438-445.
42. Tandon O.P., Verma A., Ram B.K. Cognitive dysfunction in NIDDM: P3 event related evoked potential study. Indian J. Physiol. Pharmacol. 1999, 43:383-388.
43. The Psychological Corporation The Wechsler Adult Intelligence Scale-Revised 1981, The Psychological Corporation, San Antonio.
44. Thornton S.T., Marion J.B. Classical Dynamics of Particles and Systems 2004, Thomson/Brooks/Cole, Belmont, CA, London.
45. Tun P.A., Perlmuter L.C., Russo P., Nathan D.M. Memory self-assessment and performance in aged diabetics and non-diabetics. Exp. Aging Res. 1987, 13:151-157.
46. Wahlin A., Nilsson E., Fastbom J. Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death. Neuropsychology 2002, 16:208-216.
47. van Duinkerken E., Klein M., Schoonenboom N.S., Hoogma R.P., Moll A.C., Snoek F.J., Stam C.J., Diamant M. Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study. Diabetes 2009, 58:2335-2343.
48. van Harten B., de Leeuw F.E., Weinstein H.C., Scheltens P., Biessels G.J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006, 29:2539-2548.
49. Varela F., Lachaux J.P., Rodriguez E., Martinerie J. The brainweb: phase synchronization and large-scale integration. Nat. Rev. Neurosci. 2001, 2:229-239.
50. Wessels A.M., Rombouts S.A., Remijnse P.L., Boom Y., Scheltens P., Barkhof F., Heine R.J., Snoek F.J. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 2007, 50:1763-1769.